Search

Objective: To investigate the efficacy of single-dose methotrexate treatment and the factors affecting its success in the treatment of ectopic pregnancy. Methods: Ectopic pregnancy cases treated with single dose methotrexate treatment between January 2013 and December 2017 were compared as successful and unsuccessful. Demographic characteristics of patients, ectopic mass size, beta human chorionic gonodotropin (ß-hCG) values at the beginning of treatment and at 4th and 7th days were evaluated. Results: A total of 462 patients, who underwent single dose methotrexate treatment as initial ectopic pregnancy treatment, were included in the study. Single dose methotrexate treatment was successful in 350 patients (75.8%) and failed in 112 patients (24.2%). Serum ß-hCG levels on the day of methotrexate administration, ß-hCG values at 4th day and at 7th day, and ectopic mass size were significantly higher in the failed group (p<0.001). Conclusion: There are a number of factors affecting the success of single dose methotrexate treatment in ectopic pregnancy in hemodynamically stable patients. The most important of these are ectopic mass size and initial ß-hCG value. [ABSTRACT FROM AUTHOR]

Objective: The aim of our study is to investigate serum anti- Müllerian hormone (AMH) levels in patients who developed preeclampsia at the third trimester. Methods: Our study was conducted as a prospective case control study. The patients who were diagnosed with preeclampsia over 34 weeks of gestation were included in the study. Healthy pregnant women at the same weeks of gestation were included in the control group. The demographic characteristics, clinical and laboratory parameters, gestational outcomes and serum AMH values of the patients were compared. Results: A total of 62 pregnant women (32 preeclamptic and 30 control cases) were included in our study. The demographic data were similar in two groups. Systolic blood pressure, diastolic blood pressure, uric acid value and Esbach value were found to be significantly higher in the preeclampsia group. Serum AMH values were 0.79±0.40 ng/ml in the preeclampsia group and 1.45±0.93 ng/ml in the control group (p=0.01). There was a negative correlation between serum AMH values and the systolic blood pressure (r=-0.292, p=0.02). Conclusion: Serum AMH values are lower in the preeclamptic pregnant women at the third trimester compared to normotensive pregnant women. [ABSTRACT FROM AUTHOR]

Objective: Serum anti-Müllerian hormone (AMH) levels are associated with conditions such as polycystic ovarian syndrome and obesity as well as being the marker of ovarian reserve. The aim of our study is to reveal if there is any difference between pregnant women diagnosed with gestational diabetes (GD) and healthy pregnant women in terms of third trimester AMH levels or not. Methods: Pregnant women with GD who were newly diagnosed during between 24 and 28 weeks of gestation were included in the study. The demographic characteristics, weeks of gestation, delivery week and newborn weights of all patients included in the study were recorded. The demographic characteristics, clinical and laboratory parameters, gestational outcomes and serum AMH values of the patients were compared with the control group which had similar characteristics. Results: Maternal body mass index (BMI), fasting blood glucose (FBG) and postprandial blood glucose (PBG) levels were significantly higher in the GD group than the control group. Mean serum AMH levels were similar in GD and control groups (1.37±0.80 ng/ml and 1.52±0.99 ng/ml). There was no significant correlation among serum AMH values, BMI, and FBG and PBG levels (r=-0.04, p=0.72; r=-0.03, p=0.75; r=-0.10, p=0.40, respectively). No significant impact was observed in the multiple linear regression analysis including the parameters such as age, BMI and week of gestation which may affect AMH level. Conclusion: Third trimester serum AMH levels seem similar in pregnant women with and without the diagnosis of GD. [ABSTRACT FROM AUTHOR]

The aim of this review is to summarize the cases of parasitic myomas after laparoscopic surgery. A literature search was performed using the PubMed database for the period of January 1997 to December 2014. We used the following keywords: “laparoscopic hysterectomy,” “laparoscopic myomectomy,” “morcellation,” “parasitic fibroids,” “parasitic myomas,” and “leiomyomatosis.” A total of 29 articles meeting the selection criteria were included in our review, describing 53 patients who underwent surgery for parasitic myomas. Parasitic myoma is a rare condition resulting from the small fibroid fragments left after morcellation and can be either asymptomatic or symptomatic. Although it is rare, patients should be informed about the risk of this condition after laparoscopic surgery. It is important for surgeons to look for small fibroid fragments during and after morcellation and make an effort to remove every piece of tissue. [ABSTRACT FROM AUTHOR]

The aim of this review is to summarize the cases of parasitic myomas after laparoscopic surgery. A literature search was performed using the PubMed database for the period of January 1997 to December 2014. We used the following keywords: "laparoscopic hysterectomy," "laparoscopic myomectomy," "morcellation," "parasitic fibroids," "parasitic myomas," and "leiomyomatosis." A total of 29 articles meeting the selection criteria were included in our review, describing 53 patients who underwent surgery for parasitic myomas. Parasitic myoma is a rare condition resulting from the small fibroid fragments left after morcellation and can be either asymptomatic or symptomatic. Although it is rare, patients should be informed about the risk of this condition after laparoscopic surgery. It is important for surgeons to look for small fibroid fragments during and after morcellation and make an effort to remove every piece of tissue.